BFNH — BioForce Nanosciences Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $16.92m
- $16.92m
Annual cashflow statement for BioForce Nanosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -158 | -0.502 | -0.486 | -0.472 | -0.49 |
| Non-Cash Items | 158 | 0 | — | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.328 | 0.424 | 0.417 | 0.425 | 0.429 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.08 | -0.078 | -0.068 | -0.047 | -0.061 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | 0.067 | 0.049 | 0.058 | 0.047 | 0.061 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.067 | 0.049 | 0.058 | 0.047 | 0.061 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.013 | -0.029 | -0.01 | -0 | 0 |